The survival status evaluation of 6 genes was computed by the Survival package in R. IDH2 and ARL14 were identified as independent prognostic indicators (Fig. 7a, b), and the hypomethylation of IDH2 and hypermethylation of ARL14 were related to worse prognosis in BC patients. The gene discussed is ARL14; the disease is breast cancer.